Dashboard
Manage Tickers

QURE


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-uniqure-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on uniQ...
08/20/2024 10:28:22

HC Wainwright & Co. analyst Patrick Trucchio reiterates uniQure (NASDAQ:QURE) with a Buy and maintains $25 price target.

uniqure-doses-first-patient-in-phase-iiia-clinical-trial-of-amt-191-for-fabry-disease
uniQure Doses First Patient In Phase I/IIa...
08/15/2024 11:09:57

goldman-sachs-maintains-neutral-on-uniqure-raises-price-target-to-10
Goldman Sachs Maintains Neutral on uniQure...
08/02/2024 17:00:13

Goldman Sachs analyst Salveen Richter maintains uniQure (NASDAQ:QURE) with a Neutral and raises the price target from $6 to ...

uniqures-cash-position-of-approximately-524m-as-of-june-30-2024-expected-to-fund-operations-through-the-end-of-2027
uniQure's Cash Position Of Approximately $...
08/01/2024 12:00:23

uniqure-q2-2024-gaap-eps-116-inline-sales-11126m-beat-6260m-estimate
uniQure Q2 2024 GAAP EPS $(1.16), Inline, ...
08/01/2024 11:59:59

cantor-fitzgerald-reiterates-overweight-on-uniqure-maintains-24-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/16/2024 13:13:47

Cantor Fitzgerald analyst Kristen Kluska reiterates uniQure (NASDAQ:QURE) with a Overweight and maintains $24 price target.

why-conagra-brands-shares-are-trading-lower-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why ConAgra Brands Shares Are Trading Lowe...
07/11/2024 18:02:49

why-are-uniqure-shares-surging-today
Why Are UniQure Shares Surging Today?
07/10/2024 20:00:11

UniQure N.V. (NASDAQ: QURE) shares are skyrocketing Wednesday following the release of promising interim data from its Phase I/...

why-seastar-medical-holding-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why SeaStar Medical Holding Shares Are Tra...
07/10/2024 17:18:59

smart-global-posts-upbeat-results-joins-aehr-test-systems-marinemax-and-other-big-stocks-moving-higher-on-wednesday
SMART Global Posts Upbeat Results, Joins A...
07/10/2024 14:48:49

kura-sushi-posts-weak-q3-results-joins-legalzoomcom-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Kura Sushi Posts Weak Q3 Results, Joins Le...
07/10/2024 12:01:12

sp-500-edges-higher-indivior-shares-plummet
S&P 500 Edges Higher; Indivior Shares Plummet
07/09/2024 18:38:34

why-helen-of-troy-shares-are-trading-lower-by-around-30-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Helen of Troy Shares Are Trading Lower...
07/09/2024 16:59:31

crude-oil-down-1-soligenix-shares-surge
Crude Oil Down 1%; Soligenix Shares Surge
07/09/2024 16:11:44

hc-wainwright--co-reiterates-buy-on-uniqure-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on uniQ...
07/09/2024 15:57:33

HC Wainwright & Co. analyst Patrick Trucchio reiterates uniQure (NASDAQ:QURE) with a Buy and maintains $25 price target.

why-uniqure-stock-is-soaring
Why UniQure Stock Is Soaring
07/09/2024 15:55:47

UniQure shares are trading higher Tuesday after the company announced updated interim data from its ongoing U.S. and European P...

dow-falls-over-50-points-us-small-business-optimism-surges-in-june
Dow Falls Over 50 Points; US Small Busines...
07/09/2024 13:42:27

uniqures-huntingtons-disease-gene-therapy-shows-interim-results-at-24-months
uniQure's Huntington's Disease Gene Therap...
07/09/2024 11:09:30

uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical ...

genezen-to-acquire-uniqures-commercial-gene-therapy-manufacturing-operations-in-lexington-ma-financial-terms-undisclosed
Genezen to Acquire uniQure's Commercial Ge...
07/01/2024 11:14:28

Genezen, a best-in-class gene therapy CDMO, today announced an agreement to acquire uniQure's (NASDAQ:QURE) commercial gene...

fda-grants-rmat-status-to-uniqures-amt-130-gene-therapy-for-huntingtons-disease
FDA Grants RMAT Status to UniQure's AMT-13...
06/03/2024 11:17:51

uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION